Trade Ionis Pharmaceuticals, Inc. - IONS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.28 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 30.97 |
| Open | 29.93 |
| 1-Year Change | -30.93% |
| Day's Range | 29.66 - 30.27 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 30.97 | 0.60 | 1.98% | 30.37 | 31.28 | 30.37 |
| Mar 27, 2025 | 31.55 | 0.15 | 0.48% | 31.40 | 31.71 | 30.97 |
| Mar 26, 2025 | 31.32 | -0.57 | -1.79% | 31.89 | 32.03 | 30.99 |
| Mar 25, 2025 | 32.20 | -0.93 | -2.81% | 33.13 | 33.40 | 31.69 |
| Mar 24, 2025 | 33.25 | 0.45 | 1.37% | 32.80 | 33.43 | 32.37 |
| Mar 21, 2025 | 32.72 | 0.40 | 1.24% | 32.32 | 33.50 | 32.01 |
| Mar 20, 2025 | 32.57 | -0.33 | -1.00% | 32.90 | 33.67 | 32.57 |
| Mar 19, 2025 | 33.16 | 0.56 | 1.72% | 32.60 | 33.40 | 32.58 |
| Mar 18, 2025 | 32.89 | -0.81 | -2.40% | 33.70 | 33.73 | 32.87 |
| Mar 17, 2025 | 34.14 | 1.39 | 4.24% | 32.75 | 34.66 | 32.20 |
| Mar 14, 2025 | 32.74 | -0.14 | -0.43% | 32.88 | 33.13 | 32.57 |
| Mar 13, 2025 | 32.85 | 0.25 | 0.77% | 32.60 | 33.72 | 32.56 |
| Mar 12, 2025 | 33.26 | 0.27 | 0.82% | 32.99 | 34.04 | 32.84 |
| Mar 11, 2025 | 32.83 | 1.11 | 3.50% | 31.72 | 32.98 | 31.34 |
| Mar 10, 2025 | 32.12 | -1.38 | -4.12% | 33.50 | 34.17 | 31.26 |
| Mar 7, 2025 | 33.70 | 0.40 | 1.20% | 33.30 | 34.78 | 33.30 |
| Mar 6, 2025 | 34.18 | 1.22 | 3.70% | 32.96 | 34.90 | 32.96 |
| Mar 5, 2025 | 33.59 | 1.03 | 3.16% | 32.56 | 33.87 | 32.56 |
| Mar 4, 2025 | 33.32 | 1.23 | 3.83% | 32.09 | 33.49 | 31.90 |
| Mar 3, 2025 | 32.53 | -0.03 | -0.09% | 32.56 | 33.43 | 32.07 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Ionis Pharmaceuticals Company profile
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; and Kynamro an oligonucleotide inhibitor for use in patients with homozygous familial hypercholesterolemia to reduce low density lipoprotein-cholesterol, apolipoprotein B, total cholesterol, and non-high density lipoprotein. It is also developing inotersen, an antisense drug Ionis to treat patients with hereditary transthyretin amyloidosis; and volanesorsen, an antisense drug for the treatment of familial chylomicronemia syndrome and familial partial lipodystrophy. In addition, the company is developing drugs for various indications, such as cardiometabolic diseases caused by lipid disorders; cardiovascular disease, clotting disorders, and Alzheimer's and Parkinson's diseases; and acromegaly, amyotrophic lateral sclerosis, beta-thalassemia, and Huntington's disease. Ionis Pharmaceuticals, Inc. has a collaboration agreement with AstraZeneca to discover and develop antisense therapies for treating cardiovascular and metabolic diseases, and cancer; and Biogen Inc. to develop and commercialize therapies for neurological disorders, SMA, and neurodegenerative diseases. The company was formerly known as Isis Pharmaceuticals, Inc. and changed its name to Ionis Pharmaceuticals, Inc. in December 2015. Ionis Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Carlsbad, California.| Industry: | Biotechnology & Medical Research (NEC) |
2855 Gazelle Court
CARLSBAD
CALIFORNIA 92010
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com